XXSS
GENERIC MADRID TRANSACTION SENT TO IB
19/05/2026
Voltar para busca
Dado oficial do USPTO
VONTARG
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
20/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
12/12/2017
Data de registro
14/08/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
28/02/2025
Última transação
20/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
25
Localização do titular
CH
Examinador
CROWLEY, SEAN MICHAEL
Unidade examinadora
M70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Novartis AG
Representantes
Maury M. Tepper, III Tepper & Eyster, PLLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
19/05/2026
XXCR
GENERIC MADRID TRANSACTION CREATED
19/05/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
28/10/2025
C71T
CANCELLED SECTION 71
28/02/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
14/08/2023
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
21/12/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
30/11/2018
FIMP
FINAL DISPOSITION PROCESSED
30/11/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
14/11/2018
GPNX
NOTIFICATION PROCESSED BY IB
21/09/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
14/08/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
29/05/2018
PUBO
PUBLISHED FOR OPPOSITION
29/05/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
16/05/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
16/05/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/05/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/04/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/04/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/04/2018
ALIE
ASSIGNED TO LIE
19/04/2018
RFNT
REFUSAL PROCESSED BY IB
13/04/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/04/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/04/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/04/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
15/03/2018
RFRR
REFUSAL PROCESSED BY MPU
15/03/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/03/2018
CNRT
NON-FINAL ACTION WRITTEN
08/03/2018
MAFR
APPLICATION FILING RECEIPT MAILED
03/03/2018
DOCK
ASSIGNED TO EXAMINER
27/02/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/02/2018
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
20/02/2018
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
15/02/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace VONTARG ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.